Compound having activity of blocking NMDA receptor channel, and pharmaceutical agent using the same
AssigneeNational University Corporation Chiba University
InventorsKazuei Igarashi, Hiromitsu Takayama
Life of this patent
Estimating the term…
Abstract
A novel compound having NMDA receptor channel blocking activity, is provided. A pharmaceutical agent comprising the compound is also provided. The pharmaceutical agent can be used for the treatment or prevention of a disease caused by overexcitation of an NMDA receptor, and can comprise a compound having NMDA receptor channel blocking activity and represented by the formula (1), or a pharmaceutically acceptable salt thereof.
Claims2
The compound represented by the following formula (5)
A pharmaceutical agent, comprising a compound represented by the following formula (5), or a pharmaceutically acceptable salt thereof,
Dependencies are inferred from the claim text.